Dr. Carlos A. Garberoglio, MD

Dr. Garberoglio practices at Loma Linda University Medical Center in Loma Linda, California.

Dr. Garberoglio's NPI, 1750326948, was assigned on June 19, 2006. Dr. Garberoglio graduated from Universidad Nacional de Rosario Faculty of Medicine in 1973. Dr. Garberoglio holds California license A46364.

Dr. Garberoglio's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-5075.

Dr. Garberoglio's primary practice is Loma Linda University Medical Center in Loma Linda, California. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Garberoglio to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Garberoglio practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Garberoglio's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Garberoglio is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Garberoglio's licenses on file in 3 states: California, New York and Illinois.

CMS data shows 20 Medicare services from Dr. Garberoglio across 1 procedure code in 2024, all of them office visits, for 23 Medicare patients. Medicare paid $841 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Garberoglio in 2024. 75% of them have high blood pressure, and 74% have cancer. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Garberoglio's median patient age at 57, with 80% women.

In 2020, Dr. Garberoglio wrote 15 Medicare Part D claims. They cover 1 drug, with $89 in total drug cost. In 2019, CMS named 27 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Garberoglio for performance year 2024, reported as part of a group.

Dmand AI links 71 papers to Dr. Garberoglio, published from 2010 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Sentinel Lymph Node Biopsy and California. Dr. Garberoglio has published most often in Am Surg. Dr. Garberoglio's most frequent co-authors are Sharon S. Lum, MD, Maheswari Senthil, MD and Mark Evan Reeves, MD.

CMS Open Payments shows 20 general payments to Dr. Garberoglio from 4 drug and device companies from 2018 to 2022. Travel and lodging make up the largest share, 78% of the total. Intuitive Surgical, Inc. paid the most, $2,260.

Dmand AI lists 2 awards for Dr. Garberoglio, most recently ACS Fellow in 2013.

Dr. Garberoglio graduated from Universidad Nacional de Rosario Faculty of Medicine in 1973. Dr. Garberoglio is a member of ACS.

Dr. Garberoglio is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.